Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
Stepping into the Unscientific
Chapter 80

A Difficult Negotiation (Second Update)

1,438 words 5 min read 0 views 1mo ago Source ​
Skip to the end of the chapter
Prev
Next

"Breaking through other technological barriers?"

Hearing Xu Yun's words, Tian Liangwei's expression didn't change much, but Zheng Zu, standing to the side, was slightly taken aback.

Goodness!

Does this kid really think that technological barriers like those for Imidacloprid are so easy to overcome?

You need to know.

Even the fund's executives only see the company's function as that of a professional manufacturer of biological pesticides.

Even this so-called "only" represents a vast and boundless market!

However, while inwardly criticizing Xu Yun for overestimating himself, Zheng Zu maintained a very professional expression and provided a solution:

"This question is actually very simple, Dr. Xu. If the patent is in which you are the first inventor, then you can choose to receive an additional licensing fee after receiving the existing dividends."

For example, they might take 3% or 5% of sales profits; many companies like Google and Microsoft do this.

In addition, you can also choose a one-time annual purchase, license, etc., with no fewer than seven or eight specific options.

In short, if any new technology emerges, the company—or rather, University of Science and Technology of China —won't let you share it for free; it's all business, after all.

Xu Yun nodded thoughtfully.

Perhaps Zheng Zu thought his questions were a bit too ambitious and unrealistic, and might even earn him a low impression score.

But he himself knew very well that as long as that mysterious aura was there, breaking through other technological barriers was not a pipe dream.

Therefore, he certainly wouldn't feel at ease discussing follow-up matters if he didn't get an answer to this question.

Seeing that both parties had no objection to the technology-for-equity swap plan, Zheng Zu then proposed the next step:

"In that case, let's talk about the issue of each party's shareholding, which is also the most crucial step."

As he spoke, he took out a form from his briefcase, on which a considerable amount of data was clearly recorded:

"Dr. Xu, the company we're setting up will definitely be in the biopharmaceutical sector. You don't have any objections to that, do you?"

Xu Yun hummed in agreement:

"No objections."

Imidacloprid is a type of biological pesticide, so the company's nature can only be in the biopharmaceutical industry, at least for now.

Zheng Zu then continued:

As for taking shares...

The school's suggestion is that our New Venture Fund should provide eight million in cash flow, along with other additional funding, to lead the investment.

This includes, but is not limited to, the group's office locations, facilities, and a list of executive search firms, representing a 43% stake.

The School of Life Sciences invested 2 million RMB in cash flow and some additional items, acquiring a 14% stake.

20% of the employee stock option pool will be reserved for Dr. Xu, with the remainder allocated to him.

"43 + 14 + 20 equals 77100 - 77 equals 23%"

Xu Yun quickly did the mental calculations, then shook his head and said:

"Secretary-General Zheng, this ratio is too low; I cannot accept it."

Zheng Zu was clearly prepared for a protracted battle, and therefore patiently explained:

"Dr. Xu, you probably don't know, but this ratio is actually quite high, even higher than the average market rate."

The value of a patent is not determined by its future prospects or the amount of equity that investors can acquire. The patent holder's main benefit comes from subsequent dividends.

For example, Lipitor, have you heard of that drug?

Pfizer has applied for five patents for it, with US4681893 alone valued at tens of billions of dollars. However, its R&D team holds less than 0.1% of Pfizer's shares.

For example, Larry Page's PageRank patent; he's also the founder of Google.

The patent's actual value was close to $5 billion, but the technology only accounted for a little over 1% of the initial investment; the full purchase later cost 1.8 million shares of Google stock.

As he spoke, Zheng Zu sighed and said earnestly:

"Dr. Xu, if you want to sell this technology on your own, then there's nothing more to say."

Let alone ten or twenty million, we can afford forty or fifty million.

However, if you want to use its technology as equity, then we need to discuss it from an equity perspective.

The same thing would happen in other organizations, and the percentage might even be reduced to single digits.

This has nothing to do with price gouging or being unscrupulous; it's just a different business model.

Xu Yun kept her lips pursed, her expression serious.

What Zheng Zu said actually makes a lot of sense. Xu Yun had also asked around about the investment situation in the past few days.

Generally, the proportion of equity invested through technology is between 20% and 30%.

Moreover, most of these are not intellectual property rights and can be easily dismissed.

Intellectual property rights protected by law generally have a lower percentage, around 10%-15%.

Therefore, Zheng Zu's statement that the price was higher than the market price was indeed not a lie to Xu Yun.

Unless you're like Lei Jun, with a net worth of billions when Dami was founded, having been the CEO of Kingsoft, and having invested in Vancl and Cheetah Mobile, you can't possibly own 40% of the company.

But being able to understand is one thing; whether Xu Yun can accept it is another matter entirely.

At least the current figure of 23% is far below his bottom line.

After a while, Xu Yun raised his head and said:

"Secretary-General Zheng, the minimum acceptable percentage is 40%, and it must be a dual-class share structure."

I need to hold more than 50% of the voting rights, which means I will have control. If you can't agree to this, there's no point in continuing the discussion.

Dual-class shares, also known as AB shares AB shares, are essentially shares with different voting rights.

Simply put, it separates voting rights from profit-sharing rights.

For example, one Class A share has one vote, while one Class B share has ten votes.

Class A common stock is typically held by investors and public shareholders, while Class B common stock is often held by the founding team.

In this way, even if the founding team holds a small percentage of shares, they can still retain decision-making power in the company.

For example, JD.com's equity model is like this:

Although Brother Dong owns only 15.8% of the shares, he has 80% of the voting rights, thus firmly controlling JD.com.

The same applies to the "B" in BAT (Baidu, Alibaba, Tencent); Li owns only 15.9% of the shares, but his voting rights are as high as 53.5%.

The plot in some novels where the protagonist owns 80% or 90% of the shares when the company goes public is simply impossible in reality.

Zhong Shanshan's situation is extremely rare; he only owns a little over 60% of the shares, and only increased his holdings after the company went public.

Therefore, Xu Yun thought it through very clearly:

It is obviously impossible to hold a majority stake by relying solely on one technology, but control can be maintained through dual -AB shares).

Control.

This is his absolute bottom line.

The shareholding ratio is negotiable; we can even go back and forth for ten days or half a month. But there can be no compromise on the AB shares structure.

The former might mean earning less money, but with the prestige in hand, Xu Yun wasn't too worried about his income.

But the latter concerns whether their home might be raided.

"Dual-class share structure is not a problem."

Zheng Zu answered readily, clearly indicating that the fund had already considered this point:

"University of Science and Technology of China itself does not participate in corporate decision-making; this is one of our principles."

The school's industry development mainly focuses on incubation and support, since, strictly speaking, it is a political task related to social influence and the economy.

As for the shares, Dr. Xu, let me give you a number.

28%, that's really the highest it can go. Unless you can come up with some cash to invest, there's really no way.

The shareholding has increased by 5%, and I estimate that another 3% or so would be the bottom line for University of Science and Technology of China.

At this point, the upper limit for technology-based equity investment has been roughly set.

But regardless, Xu Yun still wanted to try:

"Secretary-General Zheng."

However, he had only uttered half a sentence when a hearty laugh came from outside the office:

"Secretary-General Zheng, how could you discuss equity distribution with Little Xu without our School of Physics?"

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Xu Yun

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS